Although Twitter is not my forte, trying to write some impressions in a few more words is within my abilities. I am currently sitting in the cavernous lecture hall listening to Dan VonHoff's lecture and just finished hearing Doug Blayney's Presidential Address. The challenges before us as oncologists have been well-summarized in the lectures. The question is whether we, as practicing oncolgists -- academic, private practice, industry...U.S. or global...will respond. While this blog won't likely be seen by many until there is more visibility in the launch of ASCOconnection in July, I'll tell you what my response is going to be:
1) I'm going to go by the ASCO Foundation booth and make a contribution to the leadership to legacy program. We need more young people in this field and more researchers at every level.
2) I'm going home to Colorado and will discuss with my colleagues at the University, as well as those in our network of care, the possibility of joining the ASCO QOPI initiative. I was impressed that Michigan did this, and I think we in Colorado might benefit. How often are we giving chemotherapy in the last two weeks of life? I plan to find out.
3) I will renew my lifelong commitment to clinical trials. My mantra is "a trial for every patient and every patient on a trial". With 850 drugs in the pipeline, it boarders on unethical not to try to contribute to the knowledge we need to gain.